SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001126234-22-000086
Filing Date
2022-08-19
Accepted
2022-08-18 19:55:34
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 lumo-20220818xs3.htm S-3 364308
2 EX-4.3 lumo-20220818xs3xex43.htm EX-4.3 458331
3 EX-5.1 lumo-20220818xex51.htm EX-5.1 35459
4 EX-23.1 lumo-20220818xs3xex231.htm EX-23.1 2107
5 EX-FILING FEES lumo-20220818xs3xex107.htm EX-FILING FEES 38087
6 image_0.jpg GRAPHIC 68421
7 cantorlogoa.jpg GRAPHIC 9397
8 image_0a.jpg GRAPHIC 87
9 image_4a.jpg GRAPHIC 148775
10 logofinal2x23a.jpg GRAPHIC 13261
  Complete submission text file 0001126234-22-000086.txt   1228257
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 512-215-2630
LUMOS PHARMA, INC. (Filer) CIK: 0001126234 (see all company filings)

IRS No.: 421491350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-266966 | Film No.: 221178628
SIC: 2834 Pharmaceutical Preparations